The impact of muscle relaxation techniques on the quality of life of cancer patients, as measured by the FACT-G questionnaire

Patients with cancer experience emotional distress which characterized by psychological symptoms such as anxiety or depression, psychological symptoms that arise and complex cancer processes have negative impact on their quality of life. Many cancer patients use a wide variety of techniques to improve their psychological symptoms and quality of life including relaxation therapy and specifically, Progressive Muscle Relaxation (PMR). The systematic review purpose was to review the evidence regarding the use of PMR intervention for cancer patients. Thirty four published studies and nine identified original article as potentially relevant , undertaken in the past six years until now (2013 to 2019) with data bases in Scopus, Proquest, Google Scholar, Oxford, and Science direct Searches. The information flow chart from record identification to study inclusion was conducted in accordance with the PRISMA and extracted data with PICOT. The impact of progressive muscle relaxation interventions remained in effect for between seven days and six month after the interventions.. Progressive muscle relaxation intervention is the technique including continous and systematic stretching and relaxing of the muscles until the whole body becomes relaxed. It has effects in improving depression, stress, anxiety and quality of life via physical relaxation.

Download Full-text

Assessing the impact of chemotherapy-induced nausea and vomiting on patients’ quality of life: An Arabic version of the Functional Living Index-Emesis

Journal of Oncology Pharmacy Practice ◽

10.1177/1078155221998447 ◽

2021 ◽

pp. 107815522199844

Author(s):

Abdullah M Alhammad ◽

Nora Alkhudair ◽

Rawan Alzaidi ◽

Latifa S Almosabhi ◽

Mohammad H Aljawadi

Keyword(s):

Quality Of Life ◽

Cancer Patients ◽

Arabic Language ◽

Nausea And Vomiting ◽

Cancer Center ◽

Arabic Version ◽

Patient Reported ◽

Arabic Speaking ◽

The Impact

Introduction Chemotherapy-induced nausea and vomiting is a serious complication of cancer treatment that compromises patients’ quality of life and treatment adherence, which necessitates regular assessment. Therefore, there is a need to assess patient-reported nausea and vomiting using a validated scale among Arabic speaking cancer patient population. The objective of this study was to translate and validate the Functional Living Index-Emesis (FLIE) instrument in Arabic, a patient-reported outcome measure designed to assess the influence of chemotherapy-induced nausea and vomiting on patients’ quality of life. Methods Linguistic validation of an Arabic-language version was performed. The instrument was administered to cancer patients undergoing chemotherapy in a tertiary hospital's cancer center in Saudi Arabia. Results One-hundred cancer patients who received chemotherapy were enrolled. The participants’ mean age was 53.3 ± 14.9 years, and 50% were female. Half of the participants had a history of nausea and vomiting with previous chemotherapy. The Cronbach coefficient alpha for the FLIE was 0.9606 and 0.9736 for nausea and vomiting domains, respectively, which indicated an excellent reliability for the Arabic FLIE. The mean FLIE score was 110.9 ± 23.5, indicating no or minimal impact on daily life (NIDL). Conclusions The Arabic FLIE is a valid and reliable tool among the Arabic-speaking cancer population. Thus, the Arabic version of the FLIE will be a useful tool to assess the quality of life among Arabic speaking patients receiving chemotherapy. Additionally, the translated instrument will be a useful tool for future research studies to explore new antiemetic treatments among cancer patients.

Download Full-text

The patients’ perspective on coordinated action for cancer and AMR

European Journal of Public Health ◽

10.1093/eurpub/ckaa165.1153 ◽

2020 ◽

Vol 30 (Supplement_5) ◽

Author(s):

K Apostolidis

Keyword(s):

Quality Of Life ◽

Immune System ◽

Cancer Patients ◽

Cancer Treatments ◽

Unique Challenge ◽

Coordinated Action ◽

The Impact ◽

Patients Perspective

Abstract The speaker will present the perspective of the cancer patients, and the challenges they encounter across the spectrum of care and what measures they consider relevant in terms of prevention, diagnosis, treatment and, indeed, to raise awareness of the impact of AMR on rendering cancer treatments ineffective. She will elaborate on survivorship, and on the impact of AMR on the quality of life of patients, their carers, and families. Emphasis will be given on the implications of modern therapies, such as immunotherapy, representing a unique challenge in terms of better understanding the effect on overall health of patients, with the effect they have the immune system, further weakening the patient and leaving him/her exposed to infections potentially of higher risk than cancer itself.

Download Full-text

Analysis of the Impact of Personalized Nursing Service and Hospice Care on the Quality of Life of Elderly Cancer Patients

Tobacco Regulatory Science ◽

10.18001/trs.7.4.24 ◽

2021 ◽

Vol 7 (4) ◽

pp. 469-473

Author(s):

Ting Fang ◽

Nian Wang ◽

Meng Chen ◽

Hongmei Ma

Keyword(s):

Quality Of Life ◽

Cancer Patients ◽

Advanced Cancer ◽

Hospice Care ◽

Pain Treatment ◽

Control Group ◽

Study Group ◽

The Difference ◽

The Impact

Objective Explore the impact of personalized nursing services and hospice care on the quality of life of elderly patients with advanced cancer. Method We selected 80 elderly cancer patients admitted to our hospital from September 2020 to May 2021, and divided these patients into a study group and a control group using a random number table method. The patients in the control group used conventional nursing methods to treat and care for the patients, and the patients in the study group used hospice care measures and combined personalized nursing measures. The quality of life and pain treatment effects of the two groups of patients before and after treatment were compared. Result Before treatment, the quality-of-life scores of the two groups of patients were low, and there was no statistical difference (P>0.05); After treatment, the quality of life of the two groups of patients improved, but compared with the control group, the improvement was more obvious in the study group, and the difference was statistically significant (P<0.05). In terms of pain treatment effect, the total effective rate of pain treatment in the study group was 87.5%, which was significantly better than the 62.5% in the control group. The difference was statistically significant (P<0.05). Conclusion Personalized nursing services and hospice care are conducive to improving the survival and treatment of elderly patients with advanced cancer, and can be used as a clinical application program for the care of advanced cancer patients.

Download Full-text

Effect of different modalities of treatment on the quality of life of breast cancer patients in Egypt

Eastern Mediterranean Health Journal ◽

10.26719/1997.3.1.68 ◽

1997 ◽

Vol 3 (1) ◽

pp. 68-81

Author(s):

Fatma M. El Sharkawi ◽

Mahmoud F. Sakr ◽

Hoda Y. Atta ◽

Hafez M. Ghanem

Keyword(s):

Breast Cancer ◽

Quality Of Life ◽

Cancer Therapy ◽

Adjuvant Therapy ◽

Cancer Patients ◽

Breast Cancer Patients ◽

Breast Cancer Therapy ◽

Egyptian Women ◽

The Impact

The impact of breast cancer therapy on the quality of life [QL] of Egyptian women was studied. Patients were divided into four groups:1:mastectomy alone;2:surgery plus radiotherapy;3:surgery plus chemotherapy;and 4:triple modality. The results revealed that all the four domains of QL of women having adjuvant therapy [groups 2, 3, or 4] were significantly altered compared to those who underwent mastectomy alone. Triple modality adversely affected global QL the most compared to radiotherapy or chemotherapy;radiotherapy had significantly less effect on QL compared to chemotherapy. Triple modality predicted the worst QL. QL measures should be incorporated with the traditional end points for evaluation of treatment and patients given health education on the effects of each therapy

Download Full-text

Impact of Comorbidities on Quality Of Life in Breast Cancer Patients

Indian Journal of Cardiovascular Disease in Women WINCARS ◽

10.1055/s-0038-1656491 ◽

2016 ◽

Vol 01 (04) ◽

pp. 025-028

Author(s):

Monica Irukulla ◽

Rama Vaghmare ◽

Deepa Joseph ◽

Syed Ahmed ◽

Jyothi Jonnadula ◽

...

Keyword(s):

Breast Cancer ◽

Quality Of Life ◽

Cancer Patients ◽

Physical Functioning ◽

Bodily Pain ◽

Evidence Base ◽

Breast Cancer Patients ◽

Co Morbidity ◽

The Impact

AbstractIntroduction: Comorbidities are common among cancer patients and with an aging population are becoming more prevalent. These can potentially affect the stage at diagnosis, treatment and outcomes of people with cancer. Despite the intimate relationship between comorbidity and cancer, there is limited consensus on how to record, interpret or manage comorbidities in the context of cancer. Addressing the impact of comorbid conditions in cancer patients warrants improvement in the evidence base from which to make treatment decisions for those with comorbidities.Methods: In this prospective study, 64 patients with breast cancer, underwent QOL assessment using FACT –B questionnaire at three time points- pre-radiation and three and six months post radiation.Results: 29(46%) patients had comorbidities of which 23 (35%) had cardiovascular comorbidities and 6 had other comorbidities. The co-morbidities were negatively associated with multiple domains of quality of life, including physical functioning, general health, bodily pain. Patients with diabetes and hypertension had significantly lower scores in physical functioning in comparison to patients without diabetes and hypertension, but improved after treatment. In majority of patients the overall scores were less in patients with co-morbidities compared to patients without any co-morbidity.Conclusion: Comorbidities can significantly affect the quality of life in patients with comorbidities. Hence greater research into the QOL issues for better patient care and symptom management especially during the transitioning phase from active care to follow up will help clinicians improve the quality of care and interdisciplinary co-ordination.

Download Full-text

064: The Impact of Fatigue on Quality of Life in Cancer Patients

American Journal of Epidemiology ◽

10.1093/aje/161.supplement_1.s16c ◽

2005 ◽

Vol 161 (Supplement_1) ◽

pp. S16-S16

Author(s):

JF. Grutsch ◽

D Gupta ◽

J Granick ◽

T Wodek ◽

C G Lis

Keyword(s):

Quality Of Life ◽

Cancer Patients ◽

The Impact

Download Full-text

The impact of taste and smell alterations on quality of life in head and neck cancer patients

Quality of Life Research ◽

10.1007/s11136-015-1185-2 ◽

2015 ◽

Vol 25 (6) ◽

pp. 1495-1504 ◽

Cited By ~ 22

Author(s):

M. Alvarez-Camacho ◽

S. Gonella ◽

S. Ghosh ◽

C. Kubrak ◽

R. A. Scrimger ◽

...

Keyword(s):

Quality Of Life ◽

Head And Neck Cancer ◽

Head And Neck ◽

Cancer Patients ◽

Neck Cancer ◽

The Impact ◽

Taste And Smell

Download Full-text

A randomized clinical trial to evaluate the impact of a dental care program in the quality of life of head and neck cancer patients

Clinical Oral Investigations ◽

10.1007/s00784-013-1068-2 ◽

2013 ◽

Vol 18 (4) ◽

pp. 1213-1219 ◽

Cited By ~ 2

Author(s):

Camila Samara Funk ◽

Cristine Maria Warmling ◽

Julio Baldisserotto

Keyword(s):

Quality Of Life ◽

Clinical Trial ◽

Head And Neck Cancer ◽

Head And Neck ◽

Randomized Clinical Trial ◽

Cancer Patients ◽

Dental Care ◽

Care Program ◽

The Impact

Download Full-text

Impact of therapy with epoetin alfa on clinical outcomes in patients with nonmyeloid malignancies during cancer chemotherapy in community oncology practice. Procrit Study Group.

Journal of Clinical Oncology ◽

10.1200/jco.1997.15.3.1218 ◽

1997 ◽

Vol 15 (3) ◽

pp. 1218-1234 ◽

Cited By ~ 522

Author(s):

J Glaspy ◽

R Bukowski ◽

D Steinberg ◽

C Taylor ◽

S Tchekmedyian ◽

...

Keyword(s):

Quality Of Life ◽

Functional Status ◽

Cancer Patients ◽

Hemoglobin Level ◽

Activity Level ◽

Epoetin Alfa ◽

Open Label ◽

Transfusion Requirements ◽

The Impact

PURPOSE To study the impact of Procrit (epoetin alfa; Amgen Inc, Thousand Oaks, CA) on quality of life, transfusion requirements, and hemoglobin in anemic cancer patients receiving chemotherapy. PATIENTS AND METHODS More than 500 community-based oncologists enrolled 2,342 patients with malignancies undergoing cytotoxic chemotherapy in an open-label study. Patients were treated with epoetin alfa 150 U/kg three times weekly, which could be doubled if the therapuetic response was judged inadequate. Total treatment was up to 4 months. RESULTS Of the 2,342 patients enrolled, data were available for 2,030 patients. Of the 2,030, 1,047 patients completed all 4 months of epoetin alfa therapy. Epoetin alfa was associated with significant increases in mean self-rated scores for energy level, activity level, and overall quality of life; these improvements correlated with the magnitude of the hemoglobin increase and were independent of tumor response. In addition, epoetin alfa was associated with a significant increase in mean hemoglobin and with a significant decrease in the proportion of patients requiring transfusions (baseline to final value, P < .001). Epoetin alfa was well tolerated. CONCLUSION Epoetin alfa is effective in improving the functional status and quality of life in anemic cancer patients receiving chemotherapy, as well as increasing hemoglobin level and decreasing transfusion requirements. Improvement in functional status can be attributed to an increase in hemoglobin level, demonstrating that quality of life in this group of patients can be improved by aggressively treating anemia. Further studies will be required to define the optimal doses and schedules for epoetin alfa.

Download Full-text